Advertisement
Screener

SCIENTURE HOLDINGS, INC. (SCNX) Proceeds from Issuance of Redeemable Preferred Stock

2.2 / 5 stars · 44/102 Roast Me

SCIENTURE HOLDINGS, INC. Proceeds from Issuance of Redeemable Preferred Stock

SCIENTURE HOLDINGS, INC. (SCNX) reported Proceeds from Issuance of Redeemable Preferred Stock of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-28.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock · last filed 2016-03-28

  • SCIENTURE HOLDINGS, INC. proceeds from issuance of redeemable preferred stock for the quarter ending 2015-12-31 was $0.00.
  • SCIENTURE HOLDINGS, INC. proceeds from issuance of redeemable preferred stock for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
  • SCIENTURE HOLDINGS, INC. proceeds from issuance of redeemable preferred stock for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
  • SCIENTURE HOLDINGS, INC. proceeds from issuance of redeemable preferred stock for the quarter ending 2014-09-30 was $150.00K.
  • SCIENTURE HOLDINGS, INC. proceeds from issuance of redeemable preferred stock for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
  • SCIENTURE HOLDINGS, INC. proceeds from issuance of redeemable preferred stock for fiscal 2014 was $375.00K, a 26.47% decline from fiscal 2013.
  • SCIENTURE HOLDINGS, INC. proceeds from issuance of redeemable preferred stock for fiscal 2013 was $510.00K.
Period endProceeds from Issuance of Redeemable Preferred Stock 3 monthProceeds from Issuance of Redeemable Preferred Stock 6 monthProceeds from Issuance of Redeemable Preferred Stock 9 monthProceeds from Issuance of Redeemable Preferred Stock 12 month
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28
$0.00
derived: sum of 2 quarters · filed 2016-03-28
$0.00
10-K · filed 2016-03-28
2015-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02
$0.00
10-Q · filed 2015-11-02
2015-06-30$0.00
10-Q · filed 2015-07-30
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28
$150.00K
derived: sum of 2 quarters · filed 2016-03-28
$115.00K
derived: sum of 3 quarters · filed 2016-03-28
$375.00K
10-K · filed 2016-03-28
2014-09-30$150.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02
$115.00K
derived: sum of 2 quarters · filed 2015-11-02
$375.00K
10-Q · filed 2015-11-02
$885.00K
derived: sum of 4 quarters · filed 2015-11-02
2014-06-30-$35.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30
$225.00K
10-Q · filed 2015-07-30
$735.00K
derived: sum of 3 quarters · filed 2015-07-30
$735.00K
derived: sum of 4 quarters · filed 2015-07-30
2014-03-31$260.00K
10-Q · filed 2015-05-04
$770.00K
derived: sum of 2 quarters · filed 2015-05-04
$770.00K
derived: sum of 3 quarters · filed 2015-05-04
2013-12-31$510.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23
$510.00K
derived: sum of 2 quarters · filed 2015-03-23
$510.00K
10-K · filed 2015-03-23
2013-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30
$0.00
10-Q · filed 2014-10-30
2013-06-30$0.00
10-Q · filed 2014-08-21

Similar stocks

Stock NameCountryMarket CapPE Ratio
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Dare Bioscience, Inc. (DARE)United States$0.011B
BIOVIE INC. (BIVI)United States$0.012B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Moleculin Biotech, Inc. (MBRX)United States$0.011B
MetaVia Inc. (MTVA)United States$0.011B-0.65
KALA BIO, Inc. (KALA)United States$0.011B-3.33